Novartis heart drug fails trial, curbing growth prospects

Novartis's heart failure drug Entresto failed a trial in a new use, the Swiss drugmaker said on Monday, calling into question billions of dollars in potential revenue and taking the shine off one of the company's biggest growth prospects.

from Reuters: Health News https://ift.tt/2OnUb1L